KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Long-Term Debt Repayments (2016 - 2025)

Bausch Health Companies' Long-Term Debt Repayments history spans 16 years, with the latest figure at $352.0 million for Q4 2025.

  • For Q4 2025, Long-Term Debt Repayments fell 14.36% year-over-year to $352.0 million; the TTM value through Dec 2025 reached $10.9 billion, up 646.44%, while the annual FY2025 figure was $11.2 billion, 666.51% up from the prior year.
  • Long-Term Debt Repayments for Q4 2025 was $352.0 million at Bausch Health Companies, down from $10.0 billion in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $10.0 billion in Q2 2025 and bottomed at -$2.6 billion in Q4 2021.
  • The 5-year median for Long-Term Debt Repayments is $390.0 million (2024), against an average of $831.8 million.
  • The largest annual shift saw Long-Term Debt Repayments crashed 204.84% in 2021 before it soared 1913.54% in 2025.
  • A 5-year view of Long-Term Debt Repayments shows it stood at -$2.6 billion in 2021, then soared by 123.92% to $622.0 million in 2022, then plummeted by 67.36% to $203.0 million in 2023, then soared by 102.46% to $411.0 million in 2024, then decreased by 14.36% to $352.0 million in 2025.
  • Per Business Quant, the three most recent readings for BHC's Long-Term Debt Repayments are $352.0 million (Q4 2025), $10.0 billion (Q2 2025), and $168.0 million (Q1 2025).